Evidence map›Paper›PMID 41793573›Full record

ReviewMolecular biotechnology2026

Protein Nanocages as Versatile Vectors for Nucleic Acid Delivery: Main Systems and Their Loading Mechanisms.

Carlos Francisco Coffeen, Aquetzali Estefanía Hernández-Gutiérrez, Ismael Bustos-Jaimes

Abstract readReview
In one paragraph

Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlos Francisco CoffeenDepartment of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Av. Universidad 3000, 04510, Ciudad de México, Mexico.
Aquetzali Estefanía Hernández-GutiérrezDepartment of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Av. Universidad 3000, 04510, Ciudad de México, Mexico.
Ismael Bustos-JaimesDepartment of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Av. Universidad 3000, 04510, Ciudad de México, Mexico. ismaelb@unam.mx.ORCID http://orcid.org/0000-0003-3038-8141

Funding

Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM IN200325
6 · The paper itself

Abstract

The rapid advancement of nucleic acid-based technologies, such as mRNA vaccines and CRISPR-based gene editing, has transformed modern medicine. Yet, their full therapeutic potential remains constrained by the need for precise cargo loading and efficient delivery. This limitation has inspired the development of novel vector systems capable of both protecting nucleic acids and directing them to specific cellular targets. Protein nanocages have emerged as a highly versatile and programmable class of delivery vectors. Considerable research has focused on repurposing and engineering various platforms, including virus-like particles, encapsulins, and ferritins, to serve as robust nanocarriers. Using innovative strategies, researchers have developed sophisticated cargo-loading mechanisms that have evolved from simple electrostatic attraction to high-specificity, affinity-based systems that mimic viral packaging. At the same time, a deeper understanding of how nucleic acids interact with the nanocage interior is revealing some key structural factors that drive efficient packaging. In this review, we highlight the key advances in the design and application of protein nanocages for nucleic acid delivery. We analyze the primary systems and their distinct loading mechanisms, discuss current challenges, and explore future directions to help establish engineered nanomaterials as a new and powerful category of medical therapies.

Indexed as

Gene Transfer TechniquesNanostructuresNucleic AcidsProteinsAnimalsHumansNucleic AcidsProteinsGene therapyMRNA therapeuticsNucleic acid deliveryProtein nanocagesVirus-like particle

Identifiers

PMID41793573
PMCPMC13279676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.